Literature DB >> 16027435

Imaging and other biomarkers in early clinical studies: one step at a time or re-engineering drug development?

Jerry M Collins.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16027435     DOI: 10.1200/JCO.2005.05.907

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Imaging in drug development: will it deliver on the promise of personalised medicine?

Authors:  A Dzik-Jurasz
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

Review 2.  Drug development in oncology: classical cytotoxics and molecularly targeted agents.

Authors:  Shivaani Kummar; Martin Gutierrez; James H Doroshow; Anthony J Murgo
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

Review 3.  Next generation oncology drug development: opportunities and challenges.

Authors:  Martin E Gutierrez; Shivaani Kummar; Giuseppe Giaccone
Journal:  Nat Rev Clin Oncol       Date:  2009-05       Impact factor: 66.675

4.  Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer.

Authors:  Dan G Duda
Journal:  ISRN Cell Biol       Date:  2012

5.  Designing phase 0 cancer clinical trials.

Authors:  Anthony J Murgo; Shivaani Kummar; Larry Rubinstein; Martin Gutierrez; Jerry Collins; Robert Kinders; Ralph E Parchment; Jiuping Ji; Seth M Steinberg; Sherry X Yang; Melinda Hollingshead; Alice Chen; Lee Helman; Robert Wiltrout; Joseph E Tomaszewski; James H Doroshow
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

6.  Phase 0 clinical trials in oncology new drug development.

Authors:  Umesh Chandra Gupta; Sandeep Bhatia; Amit Garg; Amit Sharma; Vaibhav Choudhary
Journal:  Perspect Clin Res       Date:  2011-01

7.  Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva.

Authors:  S Camporesi
Journal:  Ecancermedicalscience       Date:  2008-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.